Skip to Content

InNexus Biotechnology Inc IXSBF

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IXSBF is trading at a 10% discount.
Price
$0.00
Fair Value
$4.68
Uncertainty
Extreme
1-Star Price
$4.45
5-Star Price
$3.72
Economic Moat
Ssxjpc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IXSBF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$163.20
Volume/Avg
5,000 / 5,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
IXSBF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
IXSBF
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
IXSBF
Return on Assets (Normalized)
−122.19%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−1,033.89%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRPxtk$544.0 Bil
VRTX
Vertex Pharmaceuticals IncMmjdz$108.7 Bil
REGN
Regeneron Pharmaceuticals IncLgsxyc$103.9 Bil
MRNA
Moderna IncCts$33.2 Bil
ARGX
argenx SE ADRYgl$23.4 Bil
BNTX
BioNTech SE ADRSdsw$21.7 Bil
ALNY
Alnylam Pharmaceuticals IncLylkgg$18.9 Bil
BMRN
Biomarin Pharmaceutical IncRnwltx$16.7 Bil
RPRX
Royalty Pharma PLC Class APbjxyhb$13.5 Bil
INCY
Incyte CorpKsgfzxg$13.2 Bil

Sponsor Center